![]() 987,227,520 visitors served. |
|
![]() Dictionary/ thesaurus | ![]() Medical dictionary | ![]() Legal dictionary | ![]() Financial dictionary | ![]() Acronyms | ![]() Idioms | ![]() Encyclopedia | ![]() Wikipedia encyclopedia | ? |
Hyperlipidemia |
Also found in: Dictionary/thesaurus, Acronyms, Wikipedia | 0.04 sec. |
|
hyperlipidemia /hy·per·lip·id·emia/ (-lip?i-de´me-ah) elevated concentrations of any or all of the lipids in the plasma, including hypertriglyceridemia, hypercholesterolemia, etc.hyperlipide´mic combined hyperlipidemia a generic designation for a hyperlipidemia in which several classes of lipids are elevated; usually used to denote the phenotype of a type II-b hyperlipoproteinemia. familial combined hyperlipidemia an inherited disorder of lipoprotein metabolism manifested in adulthood as hypercholesterolemia, hypertriglyceridemia, or a combination, with elevated plasma apolipoprotein B and premature coronary atherosclerosis. mixed hyperlipidemia see under hyperlipemia. remnant hyperlipidemia a form in which the accumulated lipoproteins are normally transient intermediates, chylomicron remnants, and intermediate-density lipoproteins; a generic descriptor for the type III hyperlipoproteinemia phenotype.
Hyperlipidemia A general term for elevated concentrations of any or all of the lipids in the plasma. Mentioned in: Obesity, Retinal Vein Occlusion hyperlipidemia, n an excess of lipids in the plasma, including the glycolipids, lipoproteins, and phospholipids. hyperlipidemia a general term for elevated concentrations of any or all of the lipids in the plasma. See also hyperlipoproteinemia. postprandial hyperlipidemia a normal increase following ingestion of food. primary hyperlipidemia caused by decreased activity of lipoprotein lipase, it occurs in miniature Schnauzer dogs. secondary hyperlipidemia may occur in association with diabetes mellitus, hypothyroidism, pancreatitis, hyperadrenocorticism, cholestatic liver disease and nephrotic syndrome. |
|
? Mentioned in | ? References in periodicals archive | |
|---|---|---|
The company's major products include Atelec, a long-acting calcium channel blocker and Epadel, a treatment for hyperlipidemia. J-LIT, which covers approximately 50,000 hyperlipidemia patients in Japan, is designed to examine the correlations among the administration of simvastatin, serum lipid levels, and risk of ischemic disorder. information about post-transplant complications such as rejection, infection, hypertension, renal dysfunction, hyperlipidemia, diabetes, bone disease, neurological and haematological complications and malignancy; |
| Free Tools: |
For surfers:
Browser extension |
Word of the Day |
Help
For webmasters: Free content NEW! | Linking | Lookup box | Double-click lookup | Partner with us |
|
|---|